BRCA1-associated breast tumours are mostly high-grade invasive ductal carcinomas (IDCs) that lack expression of estrogen receptor (ER), progesterone receptor (PR) and ERRB2/HER2, which is referred to as ‘triple-negative’ breast cancer (Johannsson et al, 1997). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.